Assignee
SEQIRUS UK LTD
GB·27 granted patents·30 pending applications·25 citations·filing 2013–2025
Top patents by PatentIndex Score
57 records- 0192US9801935B2Soluble needle arrays for delivery of influenza vaccinesSEQIRUS UK LTD·Filed 2016·Granted Oct 31, 2017·3 cites·10 claims
- 0292US2025288660A1Soluble needle arrays for delivery of influenza vaccinesSEQIRUS UK LTD·Filed 2024·Application pending·0 cites
- 0390US11406701B2Vaccination of immunocompromised subjectsSEQIRUS UK LTD·Filed 2020·Granted Aug 9, 2022·3 cites·20 claims
- 0489US2024424081A1Soluble needle arrays for delivery of influenza vaccinesSEQIRUS UK LTD·Filed 2024·Application pending·0 cites
- 0588US10149901B2Influenza vaccines with reduced amounts of squaleneSEQIRUS UK LTD·Filed 2016·Granted Dec 11, 2018·3 cites·24 claims
- 0685US11246921B2Influenza vaccines with reduced amounts of squaleneSEQIRUS UK LTD·Filed 2019·Granted Feb 15, 2022·1 cites·20 claims
- 0783US11013795B2Antigenically matched influenza vaccinesSEQIRUS UK LTD·Filed 2016·Granted May 25, 2021·2 cites·23 claims
- 0883US2023398203A1Soluble needle arrays for delivery of influenza vaccinesSEQIRUS UK LTD·Filed 2022·Application pending·0 cites
- 0980US9708585B2Influenza virus reassortmentSEQIRUS UK LTD·Filed 2013·Granted Jul 18, 2017·4 cites·6 claims
- 1080US9566326B2Adjuvanted influenza vaccines for pediatric useSEQIRUS UK LTD·Filed 2013·Granted Feb 14, 2017·3 cites·11 claims
- 1176US10030231B2Influenza virus reassortmentSEQIRUS UK LTD·Filed 2014·Granted Jul 24, 2018·2 cites·33 claims
- 1275US10112979B2Influenza vaccinationSEQIRUS UK LTD·Filed 2015·Granted Oct 30, 2018·1 cites·20 claims
- 1375US2024299537A1Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell cultureSEQIRUS UK LTD·Filed 2023·Application pending·0 cites
- 1474US2026000748A1Influenza vaccines with reduced amounts of squaleneSEQIRUS UK LTD·Filed 2025·Application pending·0 cites
- 1574US2022323577A1Emulsions with free aqueous-phase surfactant for adjuvanting split influenza vaccinesSEQIRUS UK LTD·Filed 2021·Application pending·0 cites
- 1671US12558412B2Vaccination of immunocompromised subjectsSEQIRUS UK LTD·Filed 2025·Granted Feb 24, 2026·0 cites·20 claims
- 1771US2026048115A1Preparation of influenza virus vaccine antigensSEQIRUS UK LTD·Filed 2025·Application pending·0 cites
- 1870US2018250381A1Soluble needle arrays for delivery of influenza vaccinesSEQIRUS UK LTD·Filed 2017·Application pending·0 cites
- 1969US10946088B2Preparation of influenza virus vaccine antigensSEQIRUS UK LTD·Filed 2015·Granted Mar 16, 2021·1 cites·22 claims
- 2068US10864264B2Influenza virus reassortmentSEQIRUS UK LTD·Filed 2019·Granted Dec 15, 2020·0 cites·42 claims
- 2167US11249088B2Influenza potency assaysSEQIRUS UK LTD·Filed 2019·Granted Feb 15, 2022·0 cites·20 claims
- 2267US9901630B2Adjuvant-sparing multi-dose influenza vaccination regimenSEQIRUS UK LTD·Filed 2014·Granted Feb 27, 2018·1 cites·22 claims
- 2367US2024050553A1Making influenza virus vaccines without using eggsSEQIRUS UK LTD·Filed 2023·Application pending·0 cites
- 2467US2024342267A1Vaccination of immunocompromised subjectsSEQIRUS UK LTD·Filed 2023·Application pending·0 cites
- 2566US12318442B2Preparation of influenza virus vaccine antigensSEQIRUS UK LTD·Filed 2021·Granted Jun 3, 2025·0 cites·19 claims
- 2666US10329537B2Influenza virus reassortmentSEQIRUS UK LTD·Filed 2014·Granted Jun 25, 2019·1 cites·7 claims
- 2766US9574181B2Influenza virus reassortment methodSEQIRUS UK LTD·Filed 2014·Granted Feb 21, 2017·0 cites·10 claims
- 2866US2020155666A1Influenza virus reassortmentSEQIRUS UK LTD·Filed 2019·Application pending·0 cites
- 2966US2019167786A1Emulsions with free aqueous-phase surfactant for adjuvanting split influenza vaccinesSEQIRUS UK LTD·Filed 2018·Application pending·0 cites
- 3065US10610584B2Reverse genetics systemsSEQIRUS UK LTD·Filed 2017·Granted Apr 7, 2020·0 cites·21 claims
- 3163US10716844B2Vaccination of immunocompromised subjectsSEQIRUS UK LTD·Filed 2020·Granted Jul 21, 2020·0 cites·15 claims
- 3262US11707520B2Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell cultureSEQIRUS UK LTD·Filed 2020·Granted Jul 25, 2023·0 cites·20 claims
- 3361US11896660B1Reducing hospitalization in elderly influenza vaccine recipientsSEQIRUS UK LTD·Filed 2017·Granted Feb 13, 2024·0 cites·21 claims
- 3460US11897918B2Compositions and methods to increase productionSEQIRUS UK LTD·Filed 2019·Granted Feb 13, 2024·0 cites·14 claims
- 3558US12083175B1Enhancement of self-amplifying mRNA molecules within lipid nanoparticlesSEQIRUS UK LTD·Filed 2021·Granted Sep 10, 2024·0 cites·29 claims
- 3658US11466257B2Cell-derived viral vaccines with low levels of residual cell DNASEQIRUS UK LTD·Filed 2020·Granted Oct 11, 2022·0 cites·13 claims
- 3758US2019142929A1Influenza vaccine regimens for pandemic associated strainsSEQIRUS UK LTD·Filed 2018·Application pending·0 cites
- 3858US2019382854A1Generic assays for detection of influenza virusesSEQIRUS UK LTD·Filed 2019·Application pending·0 cites
- 3957US2023218526A1Cold filtration of oil-in-water emulsion adjuvantsSEQIRUS UK LTD·Filed 2021·Application pending·0 cites
- 4056US2019134186A1Influenza vaccines with reduced amount of emulsion adjuvantSEQIRUS UK LTD·Filed 2018·Application pending·0 cites
- 4155US10500266B2Influenza virus reassortmentSEQIRUS UK LTD·Filed 2017·Granted Dec 10, 2019·0 cites·23 claims
- 4255US10232031B2Influenza virus reassortmentSEQIRUS UK LTD·Filed 2014·Granted Mar 19, 2019·0 cites·12 claims
- 4355US2020000909A1Influenza virus reassortmentSEQIRUS UK LTD·Filed 2019·Application pending·0 cites
- 4454US2019167780A1Influenza virus vaccinesSEQIRUS UK LTD·Filed 2018·Application pending·0 cites
- 4554US2022168413A1Adjuvanted multivalent influenza vaccinesSEQIRUS UK LTD·Filed 2020·Application pending·0 cites
- 4654US2018207258A1Adjuvanted influenza vaccines for pediatric useSEQIRUS UK LTD·Filed 2018·Application pending·0 cites
- 4754US2017202955A1Adjuvanted Influenza Vaccines for Pediatric UseSEQIRUS UK LTD·Filed 2016·Application pending·0 cites
- 4853US2019284575A1Reverse genetics using non-endogenous pol i promotersSEQIRUS UK LTD·Filed 2019·Application pending·0 cites
- 4953US2019142927A1Low-additive influenza vaccinesSEQIRUS UK LTD·Filed 2018·Application pending·0 cites
- 5051US2017304429A1Vaccination of immunocompromised subjectsSEQIRUS UK LTD·Filed 2015·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →